Hinge Health. has filed a patent for neuromodulation devices designed to treat pain and other conditions. The device generates electrical signals with specific waveforms and frequencies to interact with cellular components. The pulses are delivered through electrodes at variable intervals to prevent habituation. GlobalData’s report on Hinge Health gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Hinge Health Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Hinge Health, AI-assisted medical imaging was a key innovation area identified from patents. Hinge Health's grant share as of January 2024 was 12%. Grant share is based on the ratio of number of grants to total number of patents.

Electrical neuromodulation device for treating pain with specific waveforms

Source: United States Patent and Trademark Office (USPTO). Credit: Hinge Health Inc

A newly filed patent (Publication Number: US20240024673A1) describes a device designed for treating a tissue region in the body through electrical neuromodulation. The device includes a pair of electrodes positioned near the tissue region and a controller that transmits a pulse waveform through the electrodes. This waveform consists of a spike phase with specific amplitudes and durations, a primary phase with varying amplitudes, and a secondary phase with opposite polarity amplitudes. The device can also include multiple pairs of electrodes that are driven alternately for enhanced treatment effectiveness.

Furthermore, the patent outlines a method for electrical neuromodulation using an electrode near the tissue region of interest. This method involves transmitting specific pulse waveforms through the electrode, including spike phases, primary phases, and secondary phases with varying amplitudes and durations. The method also includes alternating pulse waveforms in direction and incorporating dead phases between primary and secondary phases. These innovative techniques aim to improve the efficacy of electrical neuromodulation treatments for various medical conditions.

To know more about GlobalData’s detailed insights on Hinge Health, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies